Middle East & Africa Genotyping Market Size & Outlook
Middle East & Africa genotyping market, 2018-2030 (US$M)
Related Markets
MEA genotyping market highlights
- The MEA genotyping market generated a revenue of USD 529.4 million in 2023.
- The market is expected to grow at a CAGR of 11.5% from 2024 to 2030.
- In terms of segment, reagents & kits was the largest revenue generating product in 2023.
- Reagents & kits is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Saudi Arabia is expected to register the highest CAGR from 2024 to 2030.
MEA data book summary
| Market revenue in 2023 | USD 529.4 million |
| Market revenue in 2030 | USD 1,135.6 million |
| Growth rate | 11.5% (CAGR from 2023 to 2030) |
| Largest segment | Reagents & kits |
| Fastest growing segment | Reagents & kits |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Reagents & kits, Services |
| Key market players worldwide | Illumina Inc, Thermo Fisher Scientific Inc, Qiagen NV, Roche, Fluidigm Corporation, Danaher Corp, Agilent Technologies, Eurofins Scientific SE, GE HealthCare Technologies Inc Common Stock, Bio-Rad Laboratories Inc |
Other key industry trends
- In terms of revenue, MEA region accounted for 3.0% of the global genotyping market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 12,067.9 million by 2030.
Key Regions: U.S. , UK , Japan , Brazil , South Africa
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Genotyping Market Scope
Genotyping Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Middle East & Africa genotyping market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to genotyping market will help companies and investors design strategic landscapes.
Reagents & kits was the largest segment with a revenue share of 61.16% in 2023. Horizon Databook has segmented the Middle East & Africa genotyping market based on instruments, reagents & kits, services covering the revenue growth of each sub-segment from 2018 to 2030.
South Africa holds large market share in MEA owing to its high economic development and improving healthcare facilities. Moreover, development of healthcare facilities is expected to contribute to growth of genotyping market in this region during the forecast period.
Considerable increase in the prevalence of cancer in Africa due to low living standards, unhealthy diet, smoking, industrial & agriculture pollution has led to increase in the need for adopting genomics research and diagnostics. There are roughly 137 and 100 people per 100,000 population in Eastern and Middle East Africa, respectively, affected with cancer.
Moreover, the cost of diagnosis is not affordable for majority of the African population, as large number of people are living below poverty line. Hence, rise in the demand for cost-effective products and proper reimbursement structure are among factors anticipated to drive the market.
Reasons to subscribe to Middle East & Africa genotyping market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa genotyping market databook
-
Our clientele includes a mix of genotyping market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa genotyping market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa genotyping market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA genotyping market size, by country, 2018-2030 (US$M)
Middle East & Africa Genotyping Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
